Pricing the EpiPen: This is Going to Sting Case Solution
How can Mylan validate the remarkable cost boosts? How can it validate the variation in costs throughout nations, as an EpiPen is priced at a substitute of $85 in France? The EpiPen situation is well fit for trainees in MBA, MBA for Executives, and also executive learning programs.
Since that time, the business both spent in advertising to increase awareness to get the drug and drastically increased the cost, raising it from $100 to $600 per 2 group in the U.S. In 2016, simmering customer anger concerning the high rates of pharmaceutical drugs lastly achieved a boiling point and also a press firestorm occurred.
PUBLICATION DATE: September 02, 2016
This is just an excerpt. This case is about SALES & MARKETING
Related Case Solutions & Analyses:
Surfside Leisurescapes
Cooperating to Compete: EGS of Turkey
Development of Food Retailing in India (A): Entry and Growth of Domestic and Foreign Players
Building a Scalable Business with Small-Holder Farmers in Kenya: Honey Care’s Beekeeping Model
Juan Valdez: Innovation in Caffeination, Spanish Version
Skype in the Voice-over-IP Industry: A Commercially Viable Blue Ocean?
Maple Leaf Simply Fresh (A)
Barcelo Hotels and Resorts (A)
Babeeze in Arms Doula Centre
Aravind Eye Care’s Vision Centers – Reaching Out to the Rural Poor
